An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

In the latest results from the 457-patient B-Clear study, published in the New England Journal of Medicine, bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis ...

Researchers in India evaluated 1387 adults with asymptomatic hepatitis B virus (HBV) infection to determine the correlation between liver-enzyme elevations and histologic disease. Presumably ...

Surrozen is dropping its sole clinical asset after the drug failed at Phase I, as the company considers a move into ophthalmology instead. Development of SZN-043 is being discontinued in severe ...

Tuck et al. discuss the unethical lack of access to diagnosis and treatment of hepatitis and consequential avoidable liver cancer cases. Existing evidence and current research in Ghana identifies ...

The management of chronic hepatitis B (CHB) during pregnancy remains a challenge and involves various aspects of maternal-fetal care. Despite the standard immunoprophylaxis, a significant portion ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

BC Children’s Hospital saw 15 admissions last year involving falls from open windows or balconies, one of the most dangerous hazards of the season. 3:00 Traffic Tips: Summer road trip safety ...

All blood donations have been screened for HIV, hepatitis B, and hepatitis C since September 1991. In Wales and Northern Ireland, GPs are already testing current and new patients, who meet the ...

While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca ... A realistic implementation ...